Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

3.4K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.4K
Viral Structure00:56

Viral Structure

62.1K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
62.1K
Overview of Exosomes01:36

Overview of Exosomes

2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Vesicular Tubular Clusters01:45

Vesicular Tubular Clusters

2.5K
After budding out from the ER membrane, some COPII vesicles lose their coat and fuse with one another to form larger vesicles and interconnected tubules called vesicular tubular clusters or VTCs. These clusters constitute a compartment at the ER-Golgi interface known as ERGIC (Endoplasmic Reticulum Golgi Intermediate Compartment). The ERGIC is a mobile membrane-bound cargo transport system that sorts proteins secreted from ER and delivers them to the Golgi.
With the help of motor proteins such...
2.5K
Overview of Secretory Vesicles01:33

Overview of Secretory Vesicles

8.5K
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
8.5K
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

6.1K
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent Progress on Carbon-Dots-Based Probes for Microbial Labeling and Versatile Analysis Applications.

Biosensors·2026
Same author

Lanthanide-doped luminescent lateral flow immunoassay for the ultrasensitive and quick detection of methyltestosterone in fish samples.

Analytical methods : advancing methods and applications·2026
Same author

Molecularly Encoded Regulation of DNA Self-Assembly Crystallization in a Closed Homogeneous Solution System.

Nano letters·2026
Same author

Ultrabright Carbon Dots as an Emerging Fluorescent Probe for Multivalent Labeling and Highly Sensitive Detection of Extracellular Vesicles.

ACS applied materials & interfaces·2026
Same author

Advanced Encapsulation Technologies for Extracellular Vesicles: From Single Units to Macroscale Packaging.

Small (Weinheim an der Bergstrasse, Germany)·2025
Same author

Recent Advances on Rapid Detection Methods of Steroid Hormones in Animal Origin Foods.

Biosensors·2025

Related Experiment Video

Updated: Jun 22, 2025

Direct Stochastic Optical Reconstruction Microscopy of Extracellular Vesicles in Three Dimensions
09:36

Direct Stochastic Optical Reconstruction Microscopy of Extracellular Vesicles in Three Dimensions

Published on: August 26, 2021

3.8K

Extracellular Vesicle Spherical Nucleic Acids.

Hao Chen1,2, Qiaojiao Ding3, Lin Li1

  • 1Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, Ningbo Cixi Institute of Biomedical Engineering, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315300, China.

JACS Au
|June 28, 2024
PubMed
Summary
This summary is machine-generated.

Researchers developed extracellular vesicle spherical nucleic acid (EV-SNA) nanostructures for enhanced drug delivery. These novel EV-SNAs offer improved biocompatibility and cellular delivery, paving the way for advanced nanomedicine applications.

More Related Videos

Extraction of Extracellular Vesicles from Whole Tissue
09:03

Extraction of Extracellular Vesicles from Whole Tissue

Published on: February 7, 2019

15.0K
Single Extracellular Vesicle Transmembrane Protein Characterization by Nano-Flow Cytometry
12:27

Single Extracellular Vesicle Transmembrane Protein Characterization by Nano-Flow Cytometry

Published on: July 26, 2022

4.7K

Related Experiment Videos

Last Updated: Jun 22, 2025

Direct Stochastic Optical Reconstruction Microscopy of Extracellular Vesicles in Three Dimensions
09:36

Direct Stochastic Optical Reconstruction Microscopy of Extracellular Vesicles in Three Dimensions

Published on: August 26, 2021

3.8K
Extraction of Extracellular Vesicles from Whole Tissue
09:03

Extraction of Extracellular Vesicles from Whole Tissue

Published on: February 7, 2019

15.0K
Single Extracellular Vesicle Transmembrane Protein Characterization by Nano-Flow Cytometry
12:27

Single Extracellular Vesicle Transmembrane Protein Characterization by Nano-Flow Cytometry

Published on: July 26, 2022

4.7K

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Molecular Biology

Background:

  • Extracellular vesicles (EVs) are natural cell-secreted nanoparticles with therapeutic potential.
  • Current limitations in EV manipulation and delivery hinder their clinical application.
  • A need exists for robust and programmable nanostructures for efficient EV-based therapies.

Purpose of the Study:

  • To develop a novel nanostructure, extracellular vesicle spherical nucleic acid (EV-SNA), for enhanced cellular delivery.
  • To engineer programmable and scalable EV-based nanocarriers.
  • To improve the delivery efficiency and biocompatibility of nucleic acid therapeutics.

Main Methods:

  • Constructed EV-SNA through hydrophobic coassembly of natural EVs with cholesterol-modified oligonucleotides.
  • Utilized programmable nucleic acid shells responding to AND logic gates for vesicle assembly control.
  • Evaluated EV-SNA stability, cellular delivery enhancement, and biocompatibility compared to artificial liposomal SNA.

Main Results:

  • EV-SNA demonstrated stability for 1 month at room temperature.
  • Achieved 10-20 times enhancement in cellular delivery capability using various EV sources.
  • EV-SNA showed superior biocompatibility and more effective delivery of antisense oligonucleotides in primary stem cells.
  • Demonstrated EV-SNA's capability for delivering functional EVs for immune regulation.

Conclusions:

  • EV-SNA represents a scalable, programmable, and highly efficient nanostructure for EV-based applications.
  • This novel platform enhances the delivery of nucleic acid therapeutics, particularly in challenging cell types.
  • EV-SNA holds significant promise for advancing drug delivery, nanovaccines, and regenerative medicine.